First Patient Enrolled in I-STEP Clinical Study of EndoBarrier in India
On February 13, 2023, GI Dynamics Inc., a medical device company, announced the enrollment of the first candidate in the I-STEP clinical trial in India. The trial aimed to assess the safety and effectiveness of the EndoBarrier® System for glycaemic improvement in patients with type 2 diabetes and obesity that is not effectively controlled.
I-STEP is a multi-centered, randomized, controlled, pivotal trial of the EndoBarrier® System in India. Around 100 candidates are expected to enroll in the trial and throughout the 24-month research period, patients treated with EndoBarrier will recei...
